Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E-COMPASSII: Cerebrolysin Combined With Rehabilitation in Subacute Stroke
NCT02768571Phase 4Completed
- Sponsor
- Samsung Medical Center
- Start
- Mar 2016
- Primary completion
- Feb 2019
- Modality
- Native Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of cerebrolysin in stroke, sponsored by Samsung Medical Center. Started Mar 2016; status: completed.
02
Drugs
cerebrolysin
03
Conditions
stroke
Beyond the preview
Go deeper on NCT02768571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02768571.